HPV-DNA test access based on self-collection of vaginal samples from women living with HIV/AIDS: pilot implementation in Brazil
DOI:
https://doi.org/10.5327/DST-2177-8264-2024361499Keywords:
HIV seropositivity, Human papillomavirus viruses , Mass screening , Uterine cervical neoplasms , Health servicesAbstract
Introduction: Women living with HIV/AIDS have a higher frequency of anogenital neoplasms resulting from human papillomavirus (HPV) infection.
The World Health Organization recommends that cervical cancer screening uses molecular tests that amplify viral genetic material, such as HPV-DNA.
In addition to collection by health professionals, self-collection of vaginal samples is a useful tool for expanding access to testing. Objective: To describe
the results of the pilot study that evaluated the acceptability of self-collection of vaginal samples and the applicability of offering HPV-DNA tests with
self-collection of vaginal samples for women living with HIV/AIDS in Brazil. Methods: Descriptive cross-sectional study involving women living with
HIV/AIDS treated in eight HIV-specialty healthcare facilities distributed in all regions of the country from May 2021 to May 2022 and a central laboratory.
Vaginal self-collection was offered, and participants were interviewed about sociodemographic data and impressions of self-collection. Results: In total,
1,919 women living with HIV/AIDS with an average age of 45 years participated in the study. Some type of HPV was detected in 66% (1,267) of cases.
The majority (71.9%) said they preferred self-collection to sample collection by health care professionals. Only 53.8% of participants underwent cytology
at the appropriate frequency, as recommended by the protocol. Conclusion: The results may support the implementation of molecular biology tests to
detect HPV in women living with HIV/AIDS, including the possibility of vaginal self-collection, promoting increased access to cervical cancer screening.
Keywords: HIV seropositivity. Human papillomavirus viruses. Mass screening. Uterine cervical neoplasms. Health services.
Downloads
References
Instituto Nacional de Câncer. Estimativa 2020: incidência de câncer no
Brasil. Rio de Janeiro: INCA; 2019.
Programa Conjunto das Nações Unidas sobre o HIV/Aids. HPV e HIV:
dois vírus, uma resposta [Internet]. UNAIDS Brasil; 2018 [cited 2022 Mar
. Available from: https://unaids.org.br/2018/10/hpv-hiv-dois-virus-umaresposta/#:~:
text=
World Health Organization. Global strategy to accelerate the elimination of
cervical cancer as a public health problem and its associated goals and targets
for the period 2020–2030. WHA73.2. Agenda item 11.4. Genebra: WHO; 2020.
Instituto Nacional de Câncer. Detecção precoce do câncer de colo de
útero. Brasil: INCA; 2022 [cited 2022 Mar 8]. Available from: https://
www.gov.br/inca/pt-br/assuntos/gestor-e-profissional-de-saude/controledo-
cancer-do-colo-do-utero/acoes/deteccao-precoce
Instituto Nacional de Câncer. Diretrizes Brasileiras para o rastreamento do
câncer do colo do útero. Rio de Janeiro: INCA; 2016.
Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional de
Saúde: Ciclos de Vida. Rio de Janeiro: IBGE; 2019.
Instituto Nacional de Câncer. Monitoramento das ações de controle do
câncer do colo do útero e mama. Boletim INCA. 2021;12(1).
Instituto Nacional de Câncer. Monitoramento das ações de controle do
câncer de pele. Boletim INCA. 2022;13(1).
Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, et al. Status of
implementation and organization of cancer screening in The European
Union Member States-Summary results from the second European screening
report. Int J Cancer. 2018;142(1):44-56. https://doi.org/10.1002/ijc.31043
Kim JJ, Burger EA, Regan C, Sy S. Screening for Cervical Cancer in Primary
Care: A Decision Analysis for the US Preventive Services Task Force.
JAMA. 2018;320(7):706-14. https://doi.org/10.1001/jama.2017.19872
Levi JE, Martins TR, Longatto-Filho A, Cohen DD, Cury L, Fuza LM,
et al. High-Risk HPV Testing in Primary Screening for Cervical Cancer
in the Public Health System, São Paulo, Brazil. Cancer Prev Res (Phila).
;12(8):539-46. https://doi.org/10.1158/1940-6207.CAPR-19-0076
World Health Organization. Laboratory diagnosis of sexually transmitted
infections, including human immunodeficiency virus. Genebra: WHO; 2013.
Teixeira JC, Vale DB, Bragança JF, Campos CS, Discacciati MG, Zeferino
LC. Cervical cancer screening program based on primary DNA-HPV
testing in a Brazilian city: A cost-effectiveness study protocol. BMC Public
Health. 2020;20(1):576. https://doi.org/10.1186/s12889-020-08688-4
World Health Organization. WHO guideline for screening and treatment
of cervical pre-cancer lesions for cervical cancer prevention. 2ª ed.
Genebra: WHO; 2021.
Ogale Y, Yeh PT, Kennedy CE, Toskin I, Narasimhan M. Self-collection of
samples as an additional approach to deliver testing services for sexually
transmitted infections: A systematic review and meta-Analysis. BMJ Glob
Health. 2019;4(2):e001349. https://doi.org/10.1136/bmjgh-2018-001349
Miranda AE, Silveira MF, Travassos AG, et al. High-risk papillomavirus
infection among women living with human Immunodeficiency virus:
Brazilian multicentric study. J Med Virol. 2017;89(12):2217-23. https://
doi.org/10.1002/jmv.24906
Woo YL, Khoo SP, Gravitt P, Hawkes D, Rajasuriar R, Saville M. The
Implementation of a Primary HPV Self-Testing Cervical Screening Program in
Malaysia through Program ROSE-Lessons Learnt and Moving Forward. Curr
Oncol. 2022;29(10):7379-87. https://doi.org/10.3390/curroncol29100579
Rodrigues LLS, Hardick J, Nicol AF, et al. Sexually transmitted infections
among HIV-infected and HIV-uninfected women in the Tapajós region,
Amazon, Brazil: Self-collected vs. clinician-collected samples. PLoS One.
;14(4):e0215001. https://doi.org/10.1371/journal.pone.0215001
Wang R, Lee K, Gaydos CA, Anderson JR, Keller J, Coleman JS.
Performance of Primary Self-Collected Human Papillomavirus Testing
Among Women Living With Human Immunodeficiency Virus in
the United States. Obstet Gynecol. 2021;137(2):342-4. https://doi.
org/10.1097/AOG.0000000000004238
Mayrand M-H, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J,
Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou
screening tests for cervical cancer. N Engl J Med. 2007;357(16):1579-88.
https://doi.org/10.1056/NEJMoa071430
Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for
primary screening of cervical cancer precursors. Cancer Epidemiol
Biomarkers Prev. 2000;9(9):945-51.
Huh WK, Ault KA, Chelmow D, Davey DD, Goulart RA, Garcia
FAR, et al. Use of primary high-risk human papillomavirus testing for
cervical cancer screening: interim clinical guidance. Obstet Gynecol.
;125(2):330-7. https://doi.org/10.1097/AOG.0000000000000669
Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, et al.
Primary cervical screening with high risk human papillomavirus testing:
observational study. BMJ. 2019;364:l240. https://doi.org/10.1136/bmj.l240
Zeferino LC, Bastos JB, do Vale DBAP, Zanine RM, Melo YLMF,
Primo WQSP, et al. Guidelines for HPV-DNA testing for cervical cancer
screening in Brazil. Rev Bras Ginecol Obstet. 2018;40(6):360-8. https://
doi.org/10.1055/s-0038-1657754
Teixeira JC, Vale DB, Campos CS, Bragança JF, Discacciati MG, Zeferino
LC. Organization of cervical cancer screening with DNA–HPV testing
impact on early–stage cancer detection: a population–based demonstration
study in a Brazilian city. Lancet Reg Heal. 2022;5:100084. https://doi.
org/10.1016/j.lana.2021.100084
Martins TR, Longatto-Filho A, Cohen D, Viscondi JYK, Fuza LM,
Cury L, et al. Influence of Prior Knowledge of Human Papillomavirus
Status on the Performance of Cytology Screening. Am J Clin Pathol.
;149(4):316-23. https://doi.org/10.1093/ajcp/aqx163
Agorastos T, Chatzistamatiou K, Tsertanidou A, Mouchtaropoulou E,
Pasentsis K, Kitsou A, et al. Implementation of HPV-based Cervical Cancer
Screening Combined with Self-sampling Using a Midwifery Network
Across Rural Greece: The GRECOSELF Study. Cancer Prev Res (Phila).
;12(10):701-10. https://doi.org/10.1158/1940-6207.CAPR-19-0192
Arbyn M, Smith SB, Temin S, Sultana F, Castle P. Detecting cervical
precancer and reaching underscreened women by using HPV testing on
self samples: updated meta-analyses. BMJ. 2018;363:k4823. https://doi.
org/10.1136/bmj.k4823
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Sexually Transmitted Diseases
This work is licensed under a Creative Commons Attribution 4.0 International License.
